FELDAN THERAPEUTICS SECURES $16.5M SERIES B TO BRING LEAD ASSET TO CLINICAL DEVELOPMENT
/PRNewswire/ - Feldan Therapeutics, a biopharmaceutical company that specializes in the development of treatments based on intracellular delivery of...
Ugur Gunaydin Francois Thomas Michaud Guy Leblanc Oligonucleotides Asos Quebec Life Sciences Gc Holdings South Korea
Source: prnewswire.com